Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Meeting ReportMolecular Targeting Technologies - Radioactive and Nonradioactive Probes: Novel Radioactive Probes

Radiosynthesis and characterization of a 68Ga-labeled uPAR-targeting peptide

Ali Azhdarinia, Pradip Ghosh, Nathaniel Wilganowski and Eva Sevick
Journal of Nuclear Medicine May 2011, 52 (supplement 1) 1494;
Ali Azhdarinia
1UTHSC-IMM, Houston, TX
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Pradip Ghosh
1UTHSC-IMM, Houston, TX
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Nathaniel Wilganowski
1UTHSC-IMM, Houston, TX
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Eva Sevick
1UTHSC-IMM, Houston, TX
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
Loading

Abstract

1494

Objectives The increased expression the urokinase plasminogen activator receptor (uPAR) in many cancer types is associated with establishment of malignant disease, proliferation and invasiveness. Interest in uPAR has intensified as its role in regulating many cancers has become clear, leading to the development of peptide-based agents that target uPAR for diagnostic and therapeutic approaches. In this study, we report the radiolabeling of a high-affinity uPAR-targeting peptide with generator-produced 68Ga, optimization of labeling conditions, and stability.

Methods A linear uPAR-targeting peptide (AE105) was synthesized and conjugated to DOTA on solid support to yield U1. 68Ga was eluted form a commercially-available generator and the eluate was either fractionated or concentrated by cation exchange. Radiolabeling was performed in sodium acetate buffer at pH 4 and heated at 95oC. Reaction conditions were optimized for heating time, peptide concentration, and buffer concentration (0.1 M or 1.25 M). Stability of the radiolabeled complex was assessed in PBS, DTPA and mouse serum.

Results Radiolabeling and purification of 68Ga-U1 resulted in radiochemical purity >99%. Dilute sodium acetate showed lower labeling yields, thus all subsequent reactions were carried out in 1.25 M sodium acetate. Longer heating improved complexation of 68Ga and reached the maximum incorporation yield at 10 mins. The impact of peptide amount was shown by low labeling yields with <10 nmol of the agent, whereas 80-92% labeling could be achieved when using 20-30 nmol. The agent proved very stable in all conditions with minimal presence of free 68Ga at 3 hrs incubation.

Conclusions A robust scheme for synthesis and purification of 68Ga-U1 was established and radiolabeling conditions were optimized. The excellent in vitro stability of the agent coupled with the favorable characteristics of 68Ga warrant pharmacological evaluation in uPAR-expressing cells

Back to top

In this issue

Journal of Nuclear Medicine
Vol. 52, Issue supplement 1
May 2011
  • Table of Contents
  • Index by author
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Radiosynthesis and characterization of a 68Ga-labeled uPAR-targeting peptide
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Radiosynthesis and characterization of a 68Ga-labeled uPAR-targeting peptide
Ali Azhdarinia, Pradip Ghosh, Nathaniel Wilganowski, Eva Sevick
Journal of Nuclear Medicine May 2011, 52 (supplement 1) 1494;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Radiosynthesis and characterization of a 68Ga-labeled uPAR-targeting peptide
Ali Azhdarinia, Pradip Ghosh, Nathaniel Wilganowski, Eva Sevick
Journal of Nuclear Medicine May 2011, 52 (supplement 1) 1494;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Info & Metrics

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

Molecular Targeting Technologies - Radioactive and Nonradioactive Probes: Novel Radioactive Probes

  • Synthesis and evaluation of novel Al-F-18-NO2A-nitroimidazole derivatives for tumor hypoxia PET
  • Radiosynthesis of [11C]SB-705498, a selective transient receptor potential Vanilloid 1 (TRPV1) receptor antagonist
  • Radiosynthesis and biological characterization studies of I-123 labeled iodosuberoylanilide hydroxamic acid (123I-ISAHA)
Show more Molecular Targeting Technologies - Radioactive and Nonradioactive Probes: Novel Radioactive Probes

Novel Radioactive Probes Posters

  • A new strategy for labeling proteins using oil-in-water emulsions. Single step preparation of Tc-99m radiolabeled insulin
  • Rapid F-18 labeling of peptides using aniline catalyzed oximation with [18F]FDG
  • Evaluation of 64Cu-labeled dipicolylamine (DPA) as a small-molecule PET probe for in vivo imaging of phosphatidylserine exposure
Show more Novel Radioactive Probes Posters

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire